XML 27 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACCOUNTING FOR STOCK BASED COMPENSATION (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options outstanding - beginning of period (in shares) 2,830,302 3,079,040 2,893,760 3,213,007
Options granted (in shares) 0 0 24,440 91,583
Options exercised (in shares) (253,182) (55,955) (339,693) (276,944)
Options forfeited (in shares) (5,625) (10,312) (7,012) (14,873)
Options outstanding - end of period (in shares) 2,571,495 3,012,773 2,571,495 3,012,773
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]        
Total options granted (in shares)     24,440 91,583
Estimated value on date of grant (in dollars per share)     $ 4.09 $ 4.82
Price methodology utilized     Black- Scholes Black- Scholes
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term Years     6 years 6 months 9 days 6 years 9 months 18 days
Interest rate (in hundredths)     1.21% 2.59%
Volatility (in hundredths)     45.17% 42.35%
Dividend yield (in hundredths)     4.04% 3.62%
Restricted stock awards, Nonvested, Number of Shares [Roll Forward]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance 328,003 324,454 324,454 309,783
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 0 0 141,289 126,304
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 0 0 (135,369) (109,649)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 0 0 (2,371) (1,984)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance 328,003 324,454 328,003 324,454
Stock Options [Member]
       
Options, Additional Disclosures [Abstract]        
Remaining unrecognized compensation expense 408 628 $ 408 $ 628